161 related articles for article (PubMed ID: 30744460)
1. Small-cell neuroendocrine carcinoma of the uterine cervix with pancreatic metastasis: a case report and a review of the literature.
Lee EJ; Hwang J; Kim DW
J Obstet Gynaecol; 2019 May; 39(4):573-575. PubMed ID: 30744460
[No Abstract] [Full Text] [Related]
2. Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy.
Embry JR; Kelly MG; Post MD; Spillman MA
Gynecol Oncol; 2011 Mar; 120(3):444-8. PubMed ID: 21138780
[TBL] [Abstract][Full Text] [Related]
3. [Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature].
Bellefqih S; Khalil J; Mezouri I; Kebdani T; Benjaafar N
Cancer Radiother; 2014 Jun; 18(3):201-7. PubMed ID: 24656987
[TBL] [Abstract][Full Text] [Related]
4. Carcinomatous meningitis during systematic chemotherapy in a patient with advanced small-cell neuroendocrine carcinoma of the uterine cervix.
Watanabe Y; Nakai H; Imaoka I; Murakami T; Hoshiai H
J Obstet Gynaecol Res; 2012 Jan; 38(1):336-9. PubMed ID: 21917069
[TBL] [Abstract][Full Text] [Related]
5. Rare case of tonsillar and subcutaneous metastasis from neuroendocrine cervical cancer.
Zeng F; Tuo Y; Liu D; He M
J Obstet Gynaecol Res; 2020 Jun; 46(6):950-954. PubMed ID: 32266759
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Miyoshi AI; Ueda Y; Kurita T; Kimura T; Yoshino K
Anticancer Res; 2023 Apr; 43(4):1397-1405. PubMed ID: 36974776
[TBL] [Abstract][Full Text] [Related]
7. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
[TBL] [Abstract][Full Text] [Related]
8. [A case of large cell neuroendocrine carcinoma (LCNEC) of the uterine cervix successfully treated by postoperative CPT-11+CDDP chemotherapy after non-curative surgery].
Tanimoto H; Hamasaki A; Akimoto Y; Honda H; Takao Y; Okamoto K; Teramoto M; Teramoto H; Kaneko M; Oshita T
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1439-41. PubMed ID: 22996787
[TBL] [Abstract][Full Text] [Related]
9. Case report: term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix.
Wu PY; Cheng YM; New GH; Chou CY; Chiang CT; Tsai HW; Huang YF
BMC Womens Health; 2017 Jul; 17(1):56. PubMed ID: 28754175
[TBL] [Abstract][Full Text] [Related]
10. Prolonged disease free survival with aggressive adjuvant chemotherapy in a case of large cell neuroendocrine carcinoma of the uterine cervix.
Markopoulos MC; Lagadas AA; Alexandrou P; Giannakopoulos KC; Polyzos A
J BUON; 2009; 14(2):322-3. PubMed ID: 19650188
[No Abstract] [Full Text] [Related]
11. High-grade neuroendocrine carcinoma of the cervix. A case report.
Baykal C; Al A; Tulunay G; Bulbul D; Güler G; Ozer S; Küçükali T
Gynecol Obstet Invest; 2005; 59(4):207-11. PubMed ID: 15746553
[TBL] [Abstract][Full Text] [Related]
12. Giant small-cell neuroendocrine carcinoma infiltrating the heart.
Płatek AE; Kowalik R; Szymanski FM; Filipiak KJ
Kardiol Pol; 2018; 76(6):1023. PubMed ID: 29905370
[No Abstract] [Full Text] [Related]
13. Treatment of High-Grade Metastatic Pancreatic Neuroendocrine Carcinoma with FOLFIRINOX.
Zhu J; Strosberg JR; Dropkin E; Strickler JH
J Gastrointest Cancer; 2015 Jun; 46(2):166-9. PubMed ID: 25662891
[No Abstract] [Full Text] [Related]
14. Large-cell neuroendocrine carcinoma of the uterine cervix complicating pregnancy.
Li WW; Yau TN; Leung CW; Pong WM; Chan MY
Hong Kong Med J; 2009 Feb; 15(1):69-72. PubMed ID: 19197101
[TBL] [Abstract][Full Text] [Related]
15. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
[TBL] [Abstract][Full Text] [Related]
16. Complete Response to Combination Nivolumab and Ipilimumab in Recurrent Neuroendocrine Carcinoma of the Cervix.
Paterniti TA; Dorr K; Ullah A; White J; Williams H; Ghamande S
Obstet Gynecol; 2021 Nov; 138(5):813-816. PubMed ID: 34619736
[TBL] [Abstract][Full Text] [Related]
17. An Unusual Case of an Extremely Large α-Fetoprotein-Producing Tumor.
Takahashi K; Tsuchiya A; Terai S
Gastroenterology; 2016 Dec; 151(6):1077-1080. PubMed ID: 28340919
[No Abstract] [Full Text] [Related]
18. Is it possible NET-redifferentiation after chemotherapy?
Ergül N; Çermik TF; Dursun N
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):31-34. PubMed ID: 31122816
[TBL] [Abstract][Full Text] [Related]
19. Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma.
De Divitiis C; von Arx C; Grimaldi AM; Cicala D; Tatangelo F; Arcella A; Romano GM; Simeone E; Iaffaioli RV; Ascierto PA; Tafuto S;
J Transl Med; 2016 May; 14(1):113. PubMed ID: 27142424
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic Metastases as the Initial Manifestation of a Neuroendocrine Carcinoma of the Uterine Cervix.
Kopke Túlio MACB; Horta MSF; Bispo MCS; Bana E Costa TSN; Chagas CMDBR
Pancreas; 2018 Feb; 47(2):e4-e5. PubMed ID: 29346219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
